Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » Drug Administration

Drug Administration

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 17/03/21 by David Breen

Pharmacist Led Myelopfoliferative Neoplasm Clinic An Audit of Current Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Pinkie Chambers

How Chemotherapy is Delivered Closer to Home: A National Scoping Survey.

Abstracts

View resources
Last reviewed: 10/07/19 by Louisa Davies

DPD deficiency testing – An Overview of Current Variations in Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Nisha Shaunak

Service impact assessment of new immunotherapy agents at Guy’s and St Thomas’ Foundation Trust (GSTFT)

Abstracts

View resources
Last reviewed: 11/07/19 by Debra Josephs

Impact assessment of cancer drug changes at Guys’ and St Thomas’ Foundation Trust (GSTFT), since introduction of the new Cancer Drugs Fund

Abstracts

View resources
Last reviewed: 10/07/19 by Rahil Ahmed

Development of a program for validation of Pharmacist carrying out SACT Verification in Small Private Hospitals

Abstracts

View resources
Last reviewed: 10/07/19 by Stephanie Lister

The Stability of Plerixafor (Mozobil) in pre-filled syringes for patient administration in an ambulatory setting.

Abstracts

View resources
Last reviewed: 10/07/19 by Rebecca Throne

Awareness and compliance with pharmacovigilance requirements amongst UK Pharmacists

Abstracts

View resources
Last reviewed: 10/07/19 by Nicholas Moyse

Comparing the Chemotherapeutic Drugs Leading Processes of Two Types of Drug Eluting Embolization Microspheres

Abstracts

View resources
Last reviewed: 10/07/19 by Rosanne J. Bruggink

The use of common Information sources by UK pharmacists to support prescribing

Abstracts

View resources
Last reviewed: 10/07/19 by John Minshull

A qualitative study of the barriers and enablers to administration of supportive therapy closer to home for breast cancer patients

Abstracts

View resources
Last reviewed: 10/07/19 by Nicola Stoner

A study to assess the feasibility of using healthy coaching session with cancer patients receiving oral systemic anticancer therapy.

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

1 2 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.